Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ), issued a statement regarding the passage of “The Ensuring Fairness in Cost-Sharing Amounts Act.” The law addresses copay accumulator programs, which impact how patient assistance from pharmaceutical manufacturers is applied to insurance out-of-pocket limits.
“Copay accumulator programs punish patients for accepting assistance from biopharmaceutical companies by preventing it from counting toward their out-of-pocket limits, forcing them to pay their deductible twice. Today’s enactment will protect those patients when a manufacturer helps to make their prescription more affordable,” Buteas said.
She also acknowledged state lawmakers and Governor Phil Murphy for their roles in advancing the legislation. “We are grateful to the legislative leaders who worked so hard to pass this important law – Senate President Nick Scutari, Senator Jon Bramnick, Assembly Majority Leader Lou Greenwald, Assemblyman Roy Freiman, and Assemblyman Sterley Stanley – and to Governor Murphy for signing it into law. This makes healthcare more affordable for New Jerseyans, and is a win for patients throughout our state.”
